Delivery Order SPE2DR25D2104-SPE2DR26F4BRT
Award Date 4/28/26
Potential Completion Date 5/19/26
Potential Value $8.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $17,119.68 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for supply of Ibrance 100 mg tablets under a firm fixed-price contract with completion by April 30, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside on a competitive basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical federal pharmaceutical distributor, particularly for military healthcare systems through...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for Ibrance 125 mg tablets (7-count packaging), with a completion date of April 22, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical extending through December 2026, which serves as the...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for supply of Ibrance 100 mg tablets under firm fixed price terms with an ultimate completion date of March 23, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside. Amerisourcebergen Drug Corp operates as a division of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The company holds a $999,999,999...
- The Defense Logistics Agency issued an $8,555.21 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for IBRANCE 125 MG CAPSULE 21S pharmaceutical supply. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 18, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty...
- <p>The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for supply of Ibrance 100 mg tablets (7-count unit).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 8, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $8,559.84 delivery order to AmerisourceBergen Drug Corp on April 3, 2026, for supply of Ibrance 100 mg tablets under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 24, 2026. No set-aside was applied to this award.</p>
- On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,559.84 to Amerisourcebergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 13, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- <p>The Defense Logistics Agency issued a $8,561.41 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Ibrance 75 mg tablets (7-count unit). Place of performance is Conshohocken, PA. Ultimate completion date is May 13, 2026. The order is firm fixed-price with no set-aside applied.</p>
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-unit package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ibrance 125 mg capsule supply (21-count packages), with completion required by March 24, 2026. Place of performance is Conshohocken, PA. The order was priced firm fixed price and carried no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...